The price tag associated with fertility drugs in this country is quite high. I see jaws dropping when I tell some patients that the medication cost associated with their treatment cycle can run between five to six thousand dollars. Good news for many is hopefully right around the corner. We heard this past Thursday that Watson Pharmaceuticals and Itero Biopharmaceuticals will be working together to develop a generic form of recombinant Follicle Stimulating Hormone. For those of you who are familiar with the different fertility drugs on the market, this would be the same as generic for Gonal-F, Bravelle or Follistim. This is huge news to me because this means more access to fertility treatment for patients who weren’t able to come up with the high price tag associated with fertility drugs. This is something I’ve been looking forward to for a long time. I will keep you updated as we learn more.
Read this link for more information: